Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract ...

The takeover also means that a related $11 billion transaction in which Novo Holdings' subsidiary Novo Nordisk takes control of three of Catalent’s fill-and-finish facilities in Italy ...

Novo Nordisk’s majority shareholder Novo Holdings is buying Catalent for $16.5 billion, and then selling the three fill-and-finish facilities in the US, Belgium, and Italy to Novo Nordisk for ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Today, Holland Bloorview Kids Rehabilitation Hospital joins KidSightstm, a pioneering data consortium created to address and close the innovation gap in pediatric health. Children and young people ...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 61 figures, this 133-page report Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Copyright © 2025 BBC. The BBC is not ...